Table 1: Demographic and clinical characteristics of study subjects.

VariablesControl ( )T1DM ( )T2DM ( ) value

Gender (M/F)64/5834/37507/359
Age (y) *## **<0.001
Duration (y)5.00 (1.00–8.00)##8.00 (3.88–13.00)0.008
ALT (U/L)18.2 (13.00–26.75)17.00 (11.00–27.50)18.0 (13.00–29.00)0.722
AST (U/L)21.0 (17.00–25.00)18.00 (15.00–25.00)19.0 (15.00–24.00)0.332
TC (mmol/L) 0.401
TG (mmol/L)1.20 (0.87–1.79)0.90 (0.71–1.33)*##1.52 (1.06–2.20)**<0.001
HDL (mmol/L) ## **<0.001
LDL (mmol/L) 0.256
BUN (mmol/L) ** **<0.001
Cr (μmol/L)67.00 (58.00–78.00)65.50 (51.25–79.75)66.00 (54.00–80.00)0.855
FPG (mmol/L) **## **<0.001
2hPG (mmol/L) ** **<0.001
HbA1c (%) ** **<0.001
GA (%) ## 0.001
CP0 (ng/mL)6.84 (5.08–9.85)0.25 (0.05–0.80)**##1.62 (1.04–2.31)**<0.001
CP120 (ng/mL)36.80 (22.44–57.97)0.40 (0.48–1.42)**3.37 (2.05–5.29)**<0.001
CP (ng/mL)28.84 (16.43–52.42)0.08 (0.00–0.62)**##1.59 (0.77–2.77)**<0.001
CA19-9 (KU/L)4.69 (2.66–9.65)18.59 (11.68–39.28)**##12.07 (6.72–21.57)**<0.001

Data represent means ± S.D. or median (interquartile range), * ,  ** versus control group; # ,   ## versus T2DM group.
ALT, aspartate aminotransferase; AST, alanine aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; FPG, fasting plasma glucose; 2hPG, 2h plasma glucose; HbA1c, glycated hemoglobin A1C; GA, glycated serum albumin; TG, total triglycerides; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CP0, C Peptide of 0 min; CP120, C Peptide of 120 min; CP, D value of C Peptide of 120 min minus C Peptide of 0 min.